$363 Million is the total value of Altium Capital Management LP's 133 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 73.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ESPR | New | ESPERION THERAPEUTICS INC NE | $12,579,000 | – | 2,515,785 | +100.0% | 3.47% | – |
| PTGX | PROTAGONIST THERAPEUTICS INC | $11,833,000 | +93.0% | 346,000 | 0.0% | 3.26% | +102.9% | |
| BLU | Sell | BELLUS HEALTH INC NEW | $11,673,000 | +6.3% | 1,450,006 | -18.9% | 3.22% | +11.7% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $10,470,000 | +173.7% | 172,000 | +87.0% | 2.89% | +187.5% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $9,404,000 | +131.5% | 331,000 | +71.5% | 2.59% | +143.2% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $8,889,000 | +49.8% | 545,000 | +17.2% | 2.45% | +57.5% |
| LNTH | Sell | LANTHEUS HLDGS INC | $7,858,000 | +5.5% | 272,000 | -6.2% | 2.17% | +11.0% |
| GOEDWS | Sell | 1847 GOEDEKER INC*w exp 99/99/999 | $7,386,000 | -36.2% | 6,103,824 | -11.4% | 2.04% | -32.9% |
| New | PEPPERLIME HEALTH ACQUSTN CO | $7,203,000 | – | 735,000 | +100.0% | 1.99% | – | |
| KROS | Sell | KEROS THERAPEUTICS INC | $6,787,000 | +36.1% | 116,000 | -7.9% | 1.87% | +43.0% |
| ILMN | Buy | ILLUMINA INC | $6,658,000 | +64.2% | 17,500 | +75.0% | 1.84% | +72.6% |
| IMTX | Sell | IMMATICS N.V | $6,317,000 | +1.4% | 469,980 | -1.9% | 1.74% | +6.7% |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $6,187,000 | – | 146,500 | +100.0% | 1.71% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $5,915,000 | – | 1,750,000 | +100.0% | 1.63% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INCcall | $5,727,000 | – | 300,000 | +100.0% | 1.58% | – |
| INSM | INSMED INC | $5,539,000 | -1.1% | 203,354 | 0.0% | 1.53% | +3.9% | |
| ISEE | Buy | IVERIC BIO INC | $5,503,000 | +3.3% | 329,101 | +0.3% | 1.52% | +8.5% |
| CTIC | Sell | CTI BIOPHARMA CORP | $5,419,000 | -44.6% | 2,185,000 | -34.0% | 1.49% | -41.7% |
| RNA | AVIDITY BIOSCIENCES INC | $5,348,000 | -3.5% | 225,000 | 0.0% | 1.48% | +1.4% | |
| INSP | Sell | INSPIRE MED SYS INC | $5,291,000 | -12.6% | 23,000 | -11.5% | 1.46% | -8.1% |
| MYGN | Buy | MYRIAD GENETICS INC | $5,244,000 | +2.8% | 190,000 | +20.3% | 1.45% | +8.1% |
| QGEN | New | QIAGEN NV | $5,169,000 | – | 93,000 | +100.0% | 1.42% | – |
| MBTC | NOCTURNE ACQUISITION CORPordinary shares | $5,000,000 | +0.2% | 500,000 | 0.0% | 1.38% | +5.3% | |
| QDEL | New | QUIDEL CORP | $4,995,000 | – | 37,000 | +100.0% | 1.38% | – |
| EPIX | New | ESSA PHARMA INC | $4,899,000 | – | 345,000 | +100.0% | 1.35% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $4,869,000 | -51.3% | 126,000 | -31.9% | 1.34% | -48.7% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $4,844,000 | -12.9% | 695,000 | +25.0% | 1.34% | -8.4% |
| ADMA | New | ADMA BIOLOGICS INC | $4,653,000 | – | 3,300,000 | +100.0% | 1.28% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $4,641,000 | – | 206,000 | +100.0% | 1.28% | – |
| VSTM | VERASTEM INC | $4,619,000 | -33.4% | 2,253,000 | 0.0% | 1.27% | -30.0% | |
| ACET | Buy | ADICET BIO INC | $4,600,000 | +312.2% | 263,000 | +84.8% | 1.27% | +332.8% |
| TVTX | TRAVERE THERAPEUTICS INC | $4,377,000 | +28.0% | 141,000 | 0.0% | 1.21% | +34.6% | |
| KLR | Sell | KALEYRA INC | $4,356,000 | -18.4% | 433,892 | -10.5% | 1.20% | -14.2% |
| GMED | Buy | GLOBUS MED INCcl a | $4,260,000 | +44.4% | 59,000 | +53.2% | 1.18% | +51.8% |
| CRIS | CURIS INC | $3,946,000 | -39.2% | 829,000 | 0.0% | 1.09% | -36.1% | |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $3,904,000 | -0.2% | 400,000 | 0.0% | 1.08% | +4.9% | |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $3,782,000 | -33.5% | 1,160,000 | -8.8% | 1.04% | -30.1% |
| GKOS | New | GLAUKOS CORP | $3,600,000 | – | 81,000 | +100.0% | 0.99% | – |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $3,560,000 | -17.6% | 440,589 | 0.0% | 0.98% | -13.3% | |
| XTNT | Sell | XTANT MED HLDGS INC | $3,498,000 | -49.6% | 6,246,291 | -0.1% | 0.96% | -47.1% |
| EXAS | New | EXACT SCIENCES CORP | $3,425,000 | – | 44,000 | +100.0% | 0.94% | – |
| NVRO | Sell | NEVRO CORP | $3,405,000 | -42.6% | 42,000 | -17.6% | 0.94% | -39.7% |
| PROF | Buy | PROFOUND MED CORP | $3,369,000 | -2.1% | 300,000 | +27.7% | 0.93% | +3.0% |
| New | PARDES BIOSCIENCES INC | $3,274,000 | – | 200,000 | +100.0% | 0.90% | – | |
| NTRA | Sell | NATERA INC | $3,269,000 | -35.5% | 35,000 | -23.1% | 0.90% | -32.3% |
| SIEN | New | SIENTRA INC | $3,178,000 | – | 866,000 | +100.0% | 0.88% | – |
| CERS | Sell | CERUS CORP | $3,167,000 | -52.7% | 465,000 | -57.7% | 0.87% | -50.3% |
| IMUX | New | IMMUNIC INC | $3,034,000 | – | 317,000 | +100.0% | 0.84% | – |
| RENOVACOR INC | $2,994,000 | -14.9% | 388,845 | 0.0% | 0.83% | -10.5% | ||
| KRMD | Buy | REPRO MED SYS INC | $2,987,000 | +9.9% | 995,500 | +4.3% | 0.82% | +15.6% |
| INFU | New | INFUSYSTEM HLDGS INC | $2,980,000 | – | 175,000 | +100.0% | 0.82% | – |
| ATEC | New | ALPHATEC HLDGS INC | $2,915,000 | – | 255,000 | +100.0% | 0.80% | – |
| HCDIP | New | HARBOR CUSTOM DEVELOPMENT IN8% conv pfd sr a | $2,901,000 | – | 185,000 | +100.0% | 0.80% | – |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $2,874,000 | -54.2% | 663,800 | -46.2% | 0.79% | -51.9% |
| MORF | MORPHIC HLDG INC | $2,843,000 | -16.3% | 60,000 | 0.0% | 0.78% | -12.0% | |
| EYPT | Sell | EYEPOINT PHARMACEUTICALS INC | $2,754,000 | -28.7% | 225,000 | -39.3% | 0.76% | -25.1% |
| TMPM | TURMERIC ACQUISITION CORPcl a | $2,494,000 | +0.3% | 254,000 | 0.0% | 0.69% | +5.5% | |
| HLXA | HELIX ACQUISITION CORP | $2,473,000 | -0.6% | 250,000 | 0.0% | 0.68% | +4.4% | |
| STAA | New | STAAR SURGICAL CO | $2,374,000 | – | 26,000 | +100.0% | 0.66% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $2,331,000 | – | 50,000 | +100.0% | 0.64% | – |
| SRSA | SARISSA CAPITAL ACQUISITN COcl a | $2,203,000 | -0.7% | 225,000 | 0.0% | 0.61% | +4.3% | |
| New | TG VENTURE ACQUISITION CORPunit 08/15/2028 | $2,050,000 | – | 200,000 | +100.0% | 0.56% | – | |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $2,034,000 | – | 24,000 | +100.0% | 0.56% | – |
| CRDF | Sell | CARDIFF ONCOLOGY INC | $2,025,000 | -12.9% | 337,000 | -3.4% | 0.56% | -8.5% |
| GIGINTERNATIONAL1 INC | $1,986,000 | +0.6% | 200,000 | 0.0% | 0.55% | +5.8% | ||
| DYN | DYNE THERAPEUTICS INC | $1,981,000 | -26.8% | 166,636 | 0.0% | 0.55% | -23.1% | |
| LAKESHORE ACQUISITION I CORPordinary shares | $1,972,000 | +0.3% | 200,000 | 0.0% | 0.54% | +5.4% | ||
| CHAVANT CAPITAL ACQUISITN COordinary shares | $1,968,000 | -0.1% | 200,000 | 0.0% | 0.54% | +5.0% | ||
| JYAC | JIYA ACQUISITION CORP | $1,954,000 | +0.2% | 200,000 | 0.0% | 0.54% | +5.5% | |
| ETNB | New | 89BIO INC | $1,934,000 | – | 148,000 | +100.0% | 0.53% | – |
| CELC | CELCUITY INC | $1,913,000 | -26.7% | 145,000 | 0.0% | 0.53% | -23.1% | |
| VQSLF | VIQ SOLUTIONS INC | $1,642,000 | -21.3% | 704,687 | 0.0% | 0.45% | -17.2% | |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $1,581,000 | – | 54,000 | +100.0% | 0.44% | – |
| New | DIGITAL HEALTH ACQUISITION Cunit 11/02/2026 | $1,536,000 | – | 150,000 | +100.0% | 0.42% | – | |
| FATBW | FAT BRANDS INC*w exp 07/16/202 | $1,533,000 | +18.2% | 227,000 | 0.0% | 0.42% | +24.4% | |
| HILLMAN SOLUTIONS CORP | $1,527,000 | -9.9% | 142,000 | 0.0% | 0.42% | -5.2% | ||
| New | AULT DISRUPTIVE TECHS CORPunit 99/99/9999 | $1,520,000 | – | 150,000 | +100.0% | 0.42% | – | |
| FLUX | Sell | FLUX PWR HLDGS INC | $1,485,000 | -44.0% | 346,268 | -33.7% | 0.41% | -41.2% |
| KALV | KALVISTA PHARMACEUTICALS INC | $1,480,000 | -24.2% | 111,834 | 0.0% | 0.41% | -20.3% | |
| GRIL | New | MUSCLE MAKER INC | $1,437,000 | – | 1,995,882 | +100.0% | 0.40% | – |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $1,395,000 | -71.2% | 293,764 | -51.8% | 0.38% | -69.7% |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $1,355,000 | +2.7% | 261,000 | +32.2% | 0.37% | +8.1% |
| New | CONTEXT THERAPEUTICS INC | $1,313,000 | – | 493,531 | +100.0% | 0.36% | – | |
| TWND | TAILWIND ACQUISITION CORP | $1,264,000 | +0.6% | 128,414 | 0.0% | 0.35% | +6.1% | |
| CCAC | CITIC CAPITAL ACQUISITION CO | $1,113,000 | +0.4% | 111,200 | 0.0% | 0.31% | +5.5% | |
| RZLT | New | REZOLUTE INC | $1,099,000 | – | 230,000 | +100.0% | 0.30% | – |
| MOTV | MOTIVE CAPITAL CORP | $1,005,000 | -0.6% | 102,099 | 0.0% | 0.28% | +4.5% | |
| New | OPY ACQUISITION CORP Iunit 09/22/2026 | $1,000,000 | – | 100,000 | +100.0% | 0.28% | – | |
| ARYD | New | ARYA SCIENCES ACQU CORP IVcl a | $992,000 | – | 100,000 | +100.0% | 0.27% | – |
| New | INDUSTRIAL HUMAN CAPITAL INC | $992,000 | – | 100,000 | +100.0% | 0.27% | – | |
| FMAC | FIRSTMARK HORIZON ACQUISITIO | $989,000 | +0.9% | 100,000 | 0.0% | 0.27% | +6.2% | |
| BLSA | BCLS ACQUISITION CORP | $980,000 | -1.6% | 100,000 | 0.0% | 0.27% | +3.4% | |
| OMEG | OMEGA ALPHA SPACcl a | $977,000 | +0.3% | 100,000 | 0.0% | 0.27% | +5.5% | |
| ACHIEVE LIFE SCIENCES INC | $949,000 | -8.5% | 122,000 | 0.0% | 0.26% | -3.7% | ||
| Sell | DOUBLEDOWN INTERACTIVE CO LTads | $944,000 | -66.5% | 60,876 | -62.0% | 0.26% | -64.8% | |
| BBIO | New | BRIDGEBIO PHARMA INCcall | $906,000 | – | 54,300 | +100.0% | 0.25% | – |
| CNTB | New | CONNECT BIOPHARMA HLDGS LTDads | $901,000 | – | 175,000 | +100.0% | 0.25% | – |
| VRCA | Sell | VERRICA PHARMACEUTICALS INC | $897,000 | -72.0% | 97,887 | -61.8% | 0.25% | -70.6% |
| COLISEUM ACQUISITION CORP | $826,000 | -2.4% | 85,000 | 0.0% | 0.23% | +2.7% | ||
| Sell | STRYVE FOODS INC | $640,000 | -40.2% | 162,121 | -18.9% | 0.18% | -37.4% | |
| New | HARBOR CUSTOM DEVELOPMENT IN*w exp 10/04/202 | $501,000 | – | 650,000 | +100.0% | 0.14% | – | |
| CLBR | COLOMBIER ACQUISITION CORPcl a | $482,000 | -0.4% | 50,000 | 0.0% | 0.13% | +4.7% | |
| ICAD | Sell | ICAD INC | $460,000 | -86.6% | 63,929 | -80.0% | 0.13% | -85.9% |
| New | IMMIX BIOPHARMA INC | $436,000 | – | 122,388 | +100.0% | 0.12% | – | |
| PALI | New | PALISADE BIO INC | $434,000 | – | 333,954 | +100.0% | 0.12% | – |
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $428,000 | +10.0% | 97,467 | 0.0% | 0.12% | +15.7% | |
| RENOVACOR INC*w exp 99/99/999 | $417,000 | -16.8% | 731,561 | 0.0% | 0.12% | -12.2% | ||
| New | MDXHEALTH SAsponsored ads | $344,000 | – | 36,159 | +100.0% | 0.10% | – | |
| HSDT | New | HELIUS MED TECHNOLOGIES INC | $254,000 | – | 48,862 | +100.0% | 0.07% | – |
| HCDIW | HARBOR CUSTOM DEVELOPMENT IN*w exp 05/09/202 | $234,000 | -33.3% | 600,000 | 0.0% | 0.06% | -29.3% | |
| New | CINGULATE INC | $232,000 | – | 83,931 | +100.0% | 0.06% | – | |
| New | AGILETHOUGHT INC | $225,000 | – | 47,670 | +100.0% | 0.06% | – | |
| New | MY SIZE INC | $210,000 | – | 416,589 | +100.0% | 0.06% | – | |
| MBTCR | NOCTURNE ACQUISITION CORPright 12/26/2025 | $200,000 | -4.8% | 500,000 | 0.0% | 0.06% | 0.0% | |
| New | CINGULATE INC*w exp 12/03/202 | $192,000 | – | 270,000 | +100.0% | 0.05% | – | |
| New | NEXGEL INC*w exp 12/01/202 | $182,000 | – | 225,000 | +100.0% | 0.05% | – | |
| New | PEPPERLIME HEALTH ACQUSTN CO*w exp 10/01/202 | $165,000 | – | 367,500 | +100.0% | 0.04% | – | |
| New | SURGEPAYS INC*w exp 10/22/202 | $161,000 | – | 250,000 | +100.0% | 0.04% | – | |
| NLSPW | New | NLS PHARMACEUTICS LTD*w exp 09/25/202 | $146,000 | – | 200,000 | +100.0% | 0.04% | – |
| LAKESHORE ACQUISITION I CORP*w exp 07/15/202 | $116,000 | +46.8% | 150,000 | 0.0% | 0.03% | +52.4% | ||
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $101,000 | +2.0% | 10,000 | 0.0% | 0.03% | +7.7% | |
| SURROZEN INC*w exp 08/01/203 | $95,000 | +1.1% | 82,233 | 0.0% | 0.03% | +4.0% | ||
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $77,000 | -28.0% | 133,333 | 0.0% | 0.02% | -25.0% | |
| New | NEXGEL INC | $75,000 | – | 28,570 | +100.0% | 0.02% | – | |
| CHAVANT CAPITAL ACQUISITN CO*w exp 99/99/999 | $74,000 | +2.8% | 150,000 | 0.0% | 0.02% | +5.3% | ||
| SRSAW | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $71,000 | -5.3% | 75,000 | 0.0% | 0.02% | 0.0% | |
| RESERVOIR MEDIA INC*w exp 08/26/202 | $70,000 | -29.3% | 50,000 | 0.0% | 0.02% | -26.9% | ||
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $51,000 | -7.3% | 84,666 | 0.0% | 0.01% | 0.0% | |
| New | INDUSTRIAL HUMAN CAPITAL INC*w exp 11/27/202 | $38,000 | – | 100,000 | +100.0% | 0.01% | – | |
| GIGINTERNATIONAL1 INC*w exp 04/19/202 | $29,000 | -21.6% | 50,000 | 0.0% | 0.01% | -20.0% | ||
| New | COLISEUM ACQUISITION CORP*w exp 08/22/202 | $23,000 | – | 28,333 | +100.0% | 0.01% | – | |
| CLBRWS | COLOMBIER ACQUISITION CORP*w exp 99/99/999 | $9,000 | 0.0% | 16,666 | 0.0% | 0.00% | 0.0% | |
| UPHWS | UPHEALTH INC*w exp 06/08/202 | $3,000 | -40.0% | 10,000 | 0.0% | 0.00% | 0.0% | |
| PSTX | Exit | POSEIDA THERAPEUTICS INC | $0 | – | -32,238 | -100.0% | -0.06% | – |
| KRYS | Exit | KRYSTAL BIOTECH INCcall | $0 | – | -5,800 | -100.0% | -0.08% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -70,000 | -100.0% | -0.10% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -59,150 | -100.0% | -0.13% | – |
| ALGS | Exit | ALIGOS THERAPEUTICS INC | $0 | – | -33,492 | -100.0% | -0.14% | – |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG Iput | $0 | – | -20,700 | -100.0% | -0.16% | – |
| ALNA | Exit | ALLENA PHARMACEUTICALS | $0 | – | -1,067,886 | -100.0% | -0.25% | – |
| Exit | ARYA SCIENCES ACQUISITN CORP | $0 | – | -100,000 | -100.0% | -0.26% | – | |
| PRQR | Exit | PROQR THRAPEUTICS N V | $0 | – | -125,000 | -100.0% | -0.27% | – |
| PODD | Exit | INSULET CORP | $0 | – | -4,250 | -100.0% | -0.32% | – |
| VRPX | Exit | VIRPAX PHARMACEUTICALS INC | $0 | – | -271,846 | -100.0% | -0.34% | – |
| PRTG | Exit | PORTAGE BIOTECH INC | $0 | – | -75,000 | -100.0% | -0.40% | – |
| VINC | Exit | VINCERX PHARMA INC | $0 | – | -107,625 | -100.0% | -0.46% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -281,790 | -100.0% | -0.46% | – |
| LFMD | Exit | LIFEMD INC | $0 | – | -288,700 | -100.0% | -0.47% | – |
| ONCR | Exit | ONCORUS INC | $0 | – | -192,054 | -100.0% | -0.47% | – |
| ELOX | Exit | ELOXX PHARMACEUTICALS INC | $0 | – | -1,118,000 | -100.0% | -0.48% | – |
| HCAQ | Exit | HEALTHCOR CATALIO ACQU CORP | $0 | – | -200,000 | -100.0% | -0.52% | – |
| FSII | Exit | FS DEVELOPMENT CORP II | $0 | – | -200,000 | -100.0% | -0.52% | – |
| YMTX | Exit | YUMANITY THERAPEUTICS INC | $0 | – | -196,000 | -100.0% | -0.53% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -108,000 | -100.0% | -0.54% | – |
| PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -775,000 | -100.0% | -0.63% | – |
| GRTX | Exit | GALERA THERAPEUTICS INC | $0 | – | -300,605 | -100.0% | -0.64% | – |
| IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -42,473 | -100.0% | -0.73% | – |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -1,250,000 | -100.0% | -0.79% | – |
| TCON | Exit | TRACON PHARMACEUTICALS INC | $0 | – | -785,341 | -100.0% | -0.80% | – |
| ADMS | Exit | ADAMAS PHARMACEUTICALS INC | $0 | – | -625,469 | -100.0% | -0.81% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -144,000 | -100.0% | -0.84% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -216,000 | -100.0% | -0.87% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -79,000 | -100.0% | -0.97% | – |
| ARCT | Exit | ARCTURUS THERAPEUTICS HLDGS | $0 | – | -80,000 | -100.0% | -1.00% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -665,000 | -100.0% | -1.08% | – |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -804,598 | -100.0% | -1.12% | – |
| VREX | Exit | VAREX IMAGING CORP | $0 | – | -158,000 | -100.0% | -1.17% | – |
| CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -72,500 | -100.0% | -1.26% | – |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -1,828,066 | -100.0% | -1.32% | – |
| HAE | Exit | HAEMONETICS CORP MASS | $0 | – | -74,000 | -100.0% | -1.37% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INCput | $0 | – | -166,700 | -100.0% | -1.44% | – |
| CDNA | Exit | CAREDX INC | $0 | – | -90,000 | -100.0% | -1.50% | – |
| ARQT | Exit | ARCUTIS BIOTHERAPEUTICS INC | $0 | – | -255,000 | -100.0% | -1.60% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -864,020 | -100.0% | -1.99% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.